14 — 9 (47) 2022 — Kalmuratova B.S., Kalenderova G.K., Elmuratova A.A., IMMUNOLOGICAL ASPECTS OF POSTCOVID SYNDROME

IMMUNOLOGICAL ASPECTS OF POSTCOVID SYNDROME

Kalmuratova B.S., Medical Institute of Karakalpakstan

Kalenderova G.K., Medical Institute of Karakalpakstan

Resume

The article presents an analysis of the clinical and immunological parameters of patients who underwent COVID-19.        

The analysis of the study showed that COVID-19 disease has a certain stage in the development of clinical manifestations, which are determined by the nature and severity of immunological disorders caused by the SARS-CoV-2 virus and the subsequent inflammatory reaction.

It has been established that PСS is characterized by an extremely wide variety of systemic, cardiopulmonary, gastrointestinal, neurological and psychosocial symptoms.

Key words: COVID-19, new coronavirus infection, postcovid syndrome, consequences of COVID-19, immune indicators.

First page

79

Last page

82

For citation: Kalmuratova B.S., Kalenderova G.K., Elmuratova A.A., IMMUNOLOGICAL ASPECTS OF POSTCOVID SYNDROME //New Day in Medicine 9 (47)2022 79 – 82 https://l.clck.bar/c5850

LIST OF REFERENCES:

  1. Адамян Л.В., Вечорко В.И., Конышева О.В. Постковидный синдром в акушерстве и репродуктивной медицине. // Проблемы репродукции 2021, Т. 27, №6, с. 30-40 https://doi.org/10.17116/repro20212706130
  2. Костинов М.П., Лукачев И.В., Мещерякова А.К. и др. Индукция эффекторов врожденного и адаптивного иммунитета в процессе лечения топической формой рекомбинантного интерферона-α2b при респираторных инфекциях. // Журнал микробиологии, эпидемиологии и иммунобиологии. 2017;(2): 38–45. DOI: 10.36233/0372-9311-2017-2-38-45.
  3. Резников Ю.П. Здоровье иммунной системы: путь, который еще не пройден. // Журнал Иммунология. Том 43. № 3. 2022. С.352-357
  4. Li H., Liu S.M., Yu X.H. et al. Coronavirus disease 2019 (COVID-19): current status and future perspectives. // Int J Antimicrob Agents.2020; 55(5): 105951. DOI: 10.1016/j.ijantimicag.2020.105951.
  5. Michelen M., Manoharan L., Elkheir N. et al. Characterising longterm Covid-19: a rapid living systematic review. medRxiv. 2020 [Preprint. Posted: August 12, 2020]. DOI: 10.1101/2020.12.08.20246025
  6. Osmanov I.M., Spiridonova E., Bobkova P. et al. Risk factors for long Covid in previously hospitalised children using the ISARIC Global follow-up protocol: A prospective cohort study. Eur. Respir. J.2021; 58 (3): 2101341. DOI: 10.1183/13993003.01341-2021.
  7. Feldstein L.R., Rose E.B., Horwitz S.M. et al. Multisystem inflammatory syndrome in U.S. children and adolescents. // N. Engl. J. Med. 2020; 383 (4): 334–346. DOI: 10.1056/NEJMoa2021680.
  8. Mutiawati E., Fahriani M., Mamada S.S., et al. Anosmia and dysgeusia in SARS-CoV-2 infection: incidence and effects on COVID-19 severity and mortality, and the possible pathobiology mechanisms – a systematic review and meta-analysis. 2021; 10: 40. DOI: 10.12688/ f1000research.28393.1
  9. Fancello V., Hatzopoulos S., Corazzi V. et al. SARSCoV-2 (COVID-19) and audio-vestibular disorders. // Int J Immunopathol Pharmacol. 2021; 35:20587384211027373. DOI:10.1177/20587384211027373
  10. Yousefi B., Valizadeh S., Ghaffari H. et al. A global treatment for coronaviruses including COVID-19. J Cell Physiol.2020; 235(12): 9133-9142. DOI: 10.1002/jcp.29785.

file

download